| 12497383 |
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Darren McMurtrie, Ryan J. SCAMP +2 more |
2025-12-16 |
|
| 12448373 |
Azetidinyl-acetamides as CXCR7 inhibitors |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Darren McMurtrie, Ryan J. SCAMP +2 more |
2025-10-21 |
|
| 12371433 |
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Darren McMurtrie, Ryan J. SCAMP +2 more |
2025-07-29 |
|
| 12139475 |
2-oxindole compounds |
Xi Chen, Dean R. Dragoli, Pingchen Fan, Manmohan Reddy Leleti, Rebecca M. Lui +6 more |
2024-11-12 |
|
| 12018016 |
Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors |
Penglie Zhang, Daniel Richard Marshall, Howard S. Roth, Aubrie Harland, Christopher W. Lange +2 more |
2024-06-25 |
$934,963,000 |
| 12011439 |
Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors |
Shijie LI, Venkat Reddy Mali, Rajinder Singh, Penglie Zhang |
2024-06-18 |
|
| 11945805 |
Inhibitors of CXCR2 |
Xi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Manmohan Reddy Leleti +6 more |
2024-04-02 |
|
| 11884654 |
Substituted anilines as CCR(4) antagonists |
Trevor T. Charvat, Junfa Fan, Christopher W. Lange, Manmohan Reddy Leleti, Yandong Li +4 more |
2024-01-30 |
|
| 11872217 |
Indanes as PD-L1 inhibitors |
Viengkham Malathong, Venkat Reddy Mali, Darren McMurtrie, Sreenivas Punna, Howard S. Roth +2 more |
2024-01-16 |
|
| 11866429 |
Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Darren McMurtrie, Ryan J. SCAMP +2 more |
2024-01-09 |
|
| 11820759 |
Modulators of chemokine receptors |
Xi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Antoni Krasinski +7 more |
2023-11-21 |
|
| 11793771 |
Immunomodulator compounds |
Christopher W. Lange, Viengkham Malathong, Darren McMurtrie, Sreenivas Punna, Rajinder Singh +1 more |
2023-10-24 |
|
| 11759458 |
Indane-amines as PD-L1 antagonists |
Christopher W. Lange, Sreenivas Punna, Rajinder Singh, Penglie Zhang |
2023-09-19 |
|
| 11713307 |
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases |
Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Darren McMurtrie, Ryan J. SCAMP +2 more |
2023-08-01 |
|
| 11708326 |
Immunomodulator compounds |
Christopher W. Lange, Viengkham Malathong, Venkat Reddy Mali, Jeffrey P. McMahon, Darren McMurtrie +5 more |
2023-07-25 |
|
| 11684606 |
Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 |
James J. CAMPBELL, Karen EBSWORTH, Antoni Krasinski, Venkat Reddy Mali, Jeffrey P. McMahon +3 more |
2023-06-27 |
|
| 11485708 |
Compounds for treatment of PD-L1 diseases |
Viengkham Malathong, Pingchen Fan, Christopher W. Lange, Venkat Reddy Mali, Darren McMurtrie +4 more |
2022-11-01 |
|
| 11446289 |
Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors |
Shijie LI, Venkat Reddy Mali, Rajinder Singh, Penglie Zhang |
2022-09-20 |
$141,892,000 |
| 11434230 |
2-oxindole compounds |
Xi Chen, Dean R. Dragoli, Pingchen Fan, Manmohan Reddy Leleti, Rebecca M. Lui +6 more |
2022-09-06 |
$69,474,000 |
| 11426364 |
Immunomodulator compounds |
Christopher W. Lange, Viengkham Malathong, Darren McMurtrie, Sreenivas Punna, Rajinder Singh +1 more |
2022-08-30 |
$69,978,000 |
| 11427541 |
Salt forms of a complement component C5A receptor |
Rajinder Singh, Kwok YAU, Yibin Zeng, Penglie Zhang, Rebecca M. Lui +1 more |
2022-08-30 |
$69,978,000 |
| 11266643 |
Triaryl compounds for treatment of PD-L1 diseases |
Pingchen Fan, Christopher W. Lange, Venkat Reddy Mali, Darren McMurtrie, Viengkham Malathong +4 more |
2022-03-08 |
$55,046,000 |
| 11207294 |
Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 |
James J. CAMPBELL, Karen EBSWORTH, Antoni Krasinski, Venkat Reddy Mali, Jeffrey P. McMahon +3 more |
2021-12-28 |
$82,819,000 |
| 11142521 |
Substituted anilines as CCR(4) antagonists |
Trevor T. Charvat, Junfa Fan, Christopher W. Lange, Manmohan Reddy Leleti, Yandong Li +4 more |
2021-10-12 |
$87,557,000 |
| 11135210 |
Indane-amines as PD-L1 antagonists |
Christopher W. Lange, Sreenivas Punna, Rajinder Singh, Penglie Zhang |
2021-10-05 |
$29,571,000 |